Synergistically enhanced Ni-MOF/CNTs nanocomposite as an electrochemical platform for ultrasensitive determination of sotagliflozin in various matrices, with whiteness and blueness assessments.

Hend Z Yamani, Yasmine H Hassan, Nancy Magdy, Maha F Abdel Ghany, Mohammed M Gomaa

Abstract read

In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Enhanced NiRSC advances · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hend Z Yamani *Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt. hend.z.yamani@pharma.asu.edu.eg.

Yasmine H Hassan *Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.

Nancy MagdyPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.

Maha F Abdel GhanyPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.

Mohammed M GomaaSolid State Physics Department, National Research Centre, Giza, 12622, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An electrochemical sensing platform based on a nickel metal-organic framework/carbon nanotubes (Ni-MOF/CNTs) nanocomposite has been developed for the determination of sotagliflozin, the first dual sodium-glucose co-transporter inhibitor recently approved by the FDA. The nanocomposite was synthesized using a simple one-pot solvothermal method and characterized by Raman spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), scanning electron microscope (SEM), and electrochemical impedance spectroscopy (EIS). The Ni-MOF/CNTs nanocomposite demonstrates superior electrochemical properties compared with its monocomponent counterparts, due to the synergistic combination of the advantages of both materials. The electrochemical behavior and the oxidation mechanism of sotagliflozin at the electrode surface were investigated using cyclic voltammetry (CV). Under optimal conditions, the sensor exhibits wide linearity across two concentration ranges: 8.0 × 10

Indexed as

Blueness assessmentElectrochemical sensorNanocompositeNi-MOF/CNTsSotagliflozinWhiteness assessment

Identifiers

PMID40415112

DOI10.1007/s00604-025-07235-5

PMCPMC12104113

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.